Unsealed<sup>188</sup> Rhenium Resin Brachytherapy in Non-Surgical Candidates With Refractory Basal Cell Carcinoma: Clinical Outcomes.
High-dose <sup>188</sup>Re brachytherapy is a noninvasive, easy to perform, well-tolerated approach to treat difficult BCC when surgery or other therapy techniques are not feasible.
Authors
- Francesco Savoia (ORCID: https://orcid.org/0000-0001-8833-2453)
- Emi Dika (ORCID: https://orcid.org/0000-0003-3186-2861)
- Giovanni Tripepi (ORCID: https://orcid.org/0000-0002-3580-4602)
- Giacomo Clarizio (ORCID: https://orcid.org/0000-0003-3849-4213)
- Lorenzo Maltoni (ORCID: https://orcid.org/0000-0002-6460-3543)
- Paolo Castellucci (ORCID: https://orcid.org/0000-0002-9215-7579)
- Bianca Maria Piraccini (ORCID: https://orcid.org/0000-0001-6537-9689)
- Federica Filippi (ORCID: https://orcid.org/0000-0001-8173-4257)
- Stefano Fanti (ORCID: https://orcid.org/0000-0003-1486-2624)
- Carlotta Baraldi (ORCID: https://orcid.org/0000-0002-3115-9407)
- Luigia Vetrone
- Federico Zagni (ORCID: https://orcid.org/0000-0002-9494-754X)
- Marco Adriano Chessa (ORCID: https://orcid.org/0000-0002-0149-8870)
- Lidia Strigari (ORCID: https://orcid.org/0000-0003-4293-2298)
- Annalisa Pitino (ORCID: https://orcid.org/0000-0002-7768-3925)
Institutions
- Istituto di Fisiologia Clinica (IT)
- Azienda USL di Bologna (IT)
- University of Bologna (IT)
Publication Details
- Journal
- PubMed
- Published
- 2025-04-01
- DOI
- https://doi.org/10.5826/dpc.1502a4933
- Citations
- 1
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35